Study on the efficacy of furosemide nebulisation in transient tachypnea of newborn

Abstract

Transient Tachypnea of the Newborn (TTN) is a prevalent cause of respiratory distress in neonates, typically arising from delayed clearance of fetal lung fluid. Although generally benign and self-limited, TTN can lead to significant morbidity, necessitating interventions to reduce respiratory symptoms, hospital stays, and the need for oxygen therapy [23,19]. The pathophysiology of TTN involves retained alveolar fluid, which hampers effective gas exchange. Furosemide, a loop diuretic known for reducing pulmonary edema, has been proposed as a potential treatment to enhance fluid